For: | Encke J, Bernardin J, Geib J, Barbakadze G, Bujdoso R, Stremmel W. Genetic vaccination with Flt3-L and GM-CSF as adjuvants: Enhancement of cellular and humoral immune responses that results in protective immunity in a murine model of hepatitis C virus infection. World J Gastroenterol 2006; 12(44): 7118-7125 [PMID: 17131473 DOI: 10.3748/wjg.v12.i44.7118] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v12/i44/7118.htm |
Number | Citing Articles |
1 |
Rémi Vernet, Emily Charrier, Erika Cosset, Sabine Fièvre, Ugo Tomasello, Julien Grogg, Nicolas Mach. Local Sustained GM-CSF Delivery by Genetically Engineered Encapsulated Cells Enhanced Both Cellular and Humoral SARS-CoV-2 Spike-Specific Immune Response in an Experimental Murine Spike DNA Vaccination Model. Vaccines 2021; 9(5): 484 doi: 10.3390/vaccines9050484
|
2 |
Istvan Berczi, Andres Quintanar‐Stephano, Kalman Kovacs. Neuroimmune Regulation in Immunocompetence, Acute Illness, and Healing. Annals of the New York Academy of Sciences 2009; 1153(1): 220 doi: 10.1111/j.1749-6632.2008.03975.x
|
3 |
Meredith Hazen, Sunil Bhakta, Rajesh Vij, Steven Randle, Dara Kallop, Vicki Chiang, Isidro Hötzel, Bijay S Jaiswal, Karen E Ervin, Bing Li, Robby M Weimer, Paul Polakis, Richard H Scheller, Jagath R Junutula, Jo-Anne S Hongo. An improved and robust DNA immunization method to develop antibodies against extra-cellular loops of multi-transmembrane proteins. mAbs 2014; 6(1): 95 doi: 10.4161/mabs.26761
|
4 |
Takeshi Wada, Michinori Kohara, Yasuhiro Yasutomi. DNA vaccine expressing the non-structural proteins of hepatitis C virus diminishes the expression of HCV proteins in a mouse model. Vaccine 2013; 31(50): 5968 doi: 10.1016/j.vaccine.2013.10.037
|
5 |
Cara K Fraser, Kerrilyn R Diener, Michael P Brown, John D Hayball. Improving vaccines by incorporating immunological coadjuvants. Expert Review of Vaccines 2007; 6(4): 559 doi: 10.1586/14760584.6.4.559
|
6 |
Jeffrey D. Ahlers, Igor M. Belyakov. Strategies for recruiting and targeting dendritic cells for optimizing HIV vaccines. Trends in Molecular Medicine 2009; 15(6): 263 doi: 10.1016/j.molmed.2009.04.003
|
7 |
O. V. Masalova, E. I. Lesnova, V. V. Grabovetskii, O. A. Smirnova, T. I. Ulanova, A. N. Burkov, A. V. Ivanov, A. D. Zaberezhnyi, R. I. Ataullakhanov, A. A. Kushch. DNA immunization with a plasmid carrying the gene of hepatitis C virus protein 5A (NS5A) induces an effective cellular immune response. Molecular Biology 2010; 44(2): 245 doi: 10.1134/S0026893310020093
|
8 |
Philip Wintermeyer, Jack R. Wands. Vaccines to prevent chronic hepatitis C virus infection: current experimental and preclinical developments. Journal of Gastroenterology 2007; 42(6): 424 doi: 10.1007/s00535-007-2057-5
|
9 |
Ashraf Elbahrawy, Hassan Atalla, Mohamed Alboraie, Ahmed Alwassief, Ali Madian, Mohammed El Fayoumie, Ashraf A. Tabll, Hussein H. Aly. Recent Advances in Protective Vaccines against Hepatitis Viruses: A Narrative Review. Viruses 2023; 15(1): 214 doi: 10.3390/v15010214
|
10 |
István Berczi, Andrés Quintanar Stephano. Insights to Neuroimmune Biology. 2016; : 185 doi: 10.1016/B978-0-12-801770-8.00008-2
|
11 |
William K. Decker, Amar Safdar. Cytokine adjuvants for vaccine therapy of neoplastic and infectious disease. Cytokine & Growth Factor Reviews 2011; 22(4): 177 doi: 10.1016/j.cytogfr.2011.07.001
|
12 |
O. V. Masalova, E. I. Lesnova, L. N. Shingarova, V. L. Tunitskaya, T. I. Ulanova, A. N. Burkov, A. A. Kushch. The combined application of nucleotide and amino acid sequences of NS3 hepatitis C virus protein, DNA encoding granulocyte macrophage colony-stimulating factor, and inhibitor of regulatory T cells induces effective immune responce against Hepatitis C virus. Molecular Biology 2012; 46(3): 473 doi: 10.1134/S0026893312030077
|
13 |
Hongtao Kang, Yinglin Qi, Hualei Wang, Xuexing Zheng, Yuwei Gao, Nan Li, Songtao Yang, Xianzhu Xia. Chimeric Rabies Virus-Like Particles Containing Membrane-Anchored GM-CSF Enhances the Immune Response against Rabies Virus. Viruses 2015; 7(3): 1134 doi: 10.3390/v7031134
|
14 |
Ali Shayeghpour, Roya Kianfar, Parastoo Hosseini, Mehdi Ajorloo, Sepehr Aghajanian, Mojtaba Hedayat Yaghoobi, Tayebeh Hashempour, Sayed-Hamidreza Mozhgani. Hepatitis C virus DNA vaccines: a systematic review. Virology Journal 2021; 18(1) doi: 10.1186/s12985-021-01716-8
|
15 |
Samaneh Karimkhanilouyi, Saeid Ghorbian. Nucleic acid vaccines for hepatitis B and C virus. Infection, Genetics and Evolution 2019; 75: 103968 doi: 10.1016/j.meegid.2019.103968
|
16 |
Olga V. Masalova, Ekaterina I. Lesnova, Alexei V. Pichugin, Tatiana M. Melnikova, Vadim V. Grabovetsky, Natalia V. Petrakova, Olga A. Smirnova, Alexander V. Ivanov, Alexei D. Zaberezhny, Ravshan I. Ataullakhanov, Maria G. Isaguliants, Alla A. Kushch. The successful immune response against hepatitis C nonstructural protein 5A (NS5A) requires heterologous DNA/protein immunization. Vaccine 2010; 28(8): 1987 doi: 10.1016/j.vaccine.2009.10.097
|
17 |
Peng Peng Ip, Hans W. Nijman, Jan Wilschut, Toos Daemen. Therapeutic vaccination against chronic hepatitis C virus infection. Antiviral Research 2012; 96(1): 36 doi: 10.1016/j.antiviral.2012.07.006
|
18 |
K. Schautteet, E. Stuyven, D.S.A. Beeckman, S. Van Acker, M. Carlon, K. Chiers, E. Cox, D. Vanrompay. Protection of pigs against Chlamydia trachomatis challenge by administration of a MOMP-based DNA vaccine in the vaginal mucosa. Vaccine 2011; 29(7): 1399 doi: 10.1016/j.vaccine.2010.12.042
|
19 |
Ioana Ghita, Evangelia Piperi, Sergei P. Atamas, Soren M. Bentzen, Robert A. Ord, Donita Dyalram, Joshua E. Lubek, Rania H. Younis. Cytokine profiling in plasma distinguishes the histological inflammatory subtype of head and neck squamous cell carcinoma and a novel regulatory role of osteopontin. Frontiers in Oral Health 2022; 3 doi: 10.3389/froh.2022.993638
|
20 |
Michael G. Tovey, Christophe Lallemand. Vaccine Adjuvants. Methods in Molecular Biology 2010; 626: 287 doi: 10.1007/978-1-60761-585-9_19
|